Next 10 |
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...
2024-04-09 09:25:02 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therap...
2024-04-09 08:43:00 ET DENVER, Colo., Apr 09, 2024 ( 247marketnews.com )- Vivos Therapeutics, Inc. (NASDAQ: VVOS ) reported that its CARE Oral Medical Devices is the first oral appliance for the treatment of all severities of obstructive sleep apnea in adults to receive all required...
LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatment...
2024-04-09 06:41:13 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics Historical earnings data for Vivos Therapeutics Financial information for Vivos Therap...
2024-04-04 13:48:01 ET DENVER, Colo., Apr 04, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Intuitive Machines, Inc. (NASDAQ: LUNR ), Boeing (NYSE: BA ), Northrop Grumman (NYSE: NOC ), Treasure & Shipwreck Recovery ...
2024-04-01 12:57:59 ET More on Mid-day movers & stocks. Meta Materials total Q4 revenue up 55% y/y Meta Materials announces $1M civil penalty to settle SEC investigation Seeking Alpha’s Quant Rating on Connect Biopharma Historical earnings data for...
2024-04-01 10:00:18 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 93.4% to $0.117 on volume of 124,152,860 shares Jaguar Health Inc. (JAGX) fell 9.0% to $0.0818 on volume of 39,020,683 shares CXApp Inc. (CXAI) rose 82.9% to $4.48 on volume of 34,784,405 shares N...
News, Short Squeeze, Breakout and More Instantly...
Vivos Therapeutics Inc. Company Name:
VVOS Stock Symbol:
NASDAQ Market:
Vivos Therapeutics (NASDAQ: VVOS) , a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, is spotlighted in a recent Proactive interview. During the interview, Vivos C...
Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million...
--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed for sleep apnea treatment. Huntsman emphasized the unique design of Vivos's ...